"Since my post reached the IHUB board, I guess I should redefine my question. Besides the $69M development cost and the $520M+ that ARIAD is getting once RIDA is approved, would ARIAD still get anything if RIDA is sold by Merck as a solo drug or in combo with other drug? "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.